MedTrace Logo

Predictive Value of Venous Excess Ultrasound Score in Management of Cardiorenal Patients

NCT05368766 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-05-10

No results posted yet for this study

Summary

To assess predictive value of venous excess ultrasound score in cardiorenal patient management

Conditions

  • Cardio-Renal Syndrome

Interventions

OTHER

VExUS score

The venous excess ultrasound (VExUS) score incorporates hepatic venous, intrarenal venous Doppler, inferior vena cava (IVC) assessment, and portal vein Doppler

DRUG

Diuretic Effect

Response to diuretic therapy

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abdallah I. Kelany, MD · university

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-06-01
Completion
2024-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368766 on ClinicalTrials.gov